Business

Toy touts, random spins and frantic bidding: the murky ...

Quickfire lots fuel a booming business, but critics condemn gambling-style featu...

Hen cages and pig farrowing crates to be outlawed in En...

Humane slaughter requirements for farmed fish and end to puppy farming also in n...

Best of 2025: Life in a ‘sinking nation’: Tuvalu’s drea...

Every Monday and Friday for the rest of December we will publish some of our fav...

Kimchi, made in China: how South Korea’s national dish ...

In the first 10 months of this year, South Korea imported $159m worth of kimchi,...

The Guardian view on Labour’s difficult year: denial of...

All the incentives in Westminster politics militate against confronting difficul...

Footage shows US forces seizing second oil tanker off V...

A video posted on the X account of the US homeland security secretary, Kristi No...

Thanks to Donald Trump, 2025 was a good year … for whit...

Why would the Trump administration choose to set aside consequences from crimina...

Happy K-shaped Christmas

Across the US, high earners are spending while middle- and lower-income househol...

What David Ellison can learn from a hostile bid battle ...

The saga of Oracle’s PeopleSoft takeover might show what is needed to win Warner...

Apollo cuts risk and stockpiles cash in preparation for...

Marc Rowan tells investors the group is positioning itself for when ‘something b...

Larry Ellison gives $40bn personal backing to Warner Br...

Oracle co-founder has agreed to backstop Paramount’s $108bn hostile bid personally

The year of the tariff

American trade policy is geared towards re-industrialisation — and it’s working

The stock market winners and losers of 2025

Chips, gold and guns have triumphed while ad companies and private equity struggled

US halts offshore wind projects, citing national securi...

Trump administration unleashes a fresh setback for developers of renewable energy

ByteDance plans $23bn AI spending spree to keep pace wi...

TikTok’s Chinese owner set to increase capital expenditure next year in effort t...

Novo Nordisk weight-loss drug wins US approval as a dai...

Danish company will be first to market with oral obesity treatment but rival Eli...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.